CSPC Pharmaceutical Group Announces Strategic AI Collaborations with Insilico Intelligence and XtalPi to Advance Innovative Drug Discovery

Intelligent Finance APP News, CSPC Pharmaceutical Group Limited (01093) announced that the group has reached strategic cooperation agreements in the artificial intelligence (AI) field for innovative drug research and development with Insilico Medicine (Shanghai) Technology Co., Ltd. (Insilico Medicine) and XtalPi Holdings Limited (XtalPi).

Based on the agreement, the Group will fully utilize its profound experience in drug research and development, combined with the leading AI technology platforms of Insilico Medicine and XtalPi in the field of innovative drug R&D. The focus will be on strategic products with high clinical demand, using AI-assisted drug design to improve the efficiency and success rate of new drug screening, jointly promoting the R&D of the Group's innovative drugs.

InSilico Medicine is a biopharmaceutical technology company driven by generative artificial intelligence. By connecting biology, chemistry, and clinical trial analysis through next-generation AI systems, it leverages modern machine learning technologies such as deep generative models, reinforcement learning, and transformer models to build a powerful and efficient AI drug discovery platform. This platform identifies novel targets and generates candidate drugs with specific molecular structures. InSilico Medicine focuses on unmet medical needs in areas such as cancer, fibrosis, immunology, central nervous system diseases, and aging-related conditions, advancing and accelerating innovative drug development.

XtalPi is a world-leading technology company driving innovation through artificial intelligence and robotics. Founded in 2014 at the Massachusetts Institute of Technology (MIT) in the United States, XtalPi is committed to realizing digital and intelligent transformations in the life sciences and new materials fields. Leveraging cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robotics clusters, XtalPi provides innovative technologies, services, and products for global industries including biomedicine, chemicals, new energy, and advanced materials.